Order Article Reprints

Schubart C, Stöhr R, Tögel L, Fuchs F, Sirbu H, Seitz G, Seggewiss-Bernhardt R, Leistner R, Sterlacci W, Vieth M, et al. MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting. Cancers. 2021; 13(19):5023. https://doi.org/10.3390/cancers13195023

Schubart, Christoph, Robert Stöhr, Lars Tögel, Florian Fuchs, Horia Sirbu, Gerhard Seitz, Ruth Seggewiss-Bernhardt, Rumo Leistner, William Sterlacci, Michael Vieth, and et al. 2021. "MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting" Cancers 13, no. 19: 5023. https://doi.org/10.3390/cancers13195023

Schubart, C., Stöhr, R., Tögel, L., Fuchs, F., Sirbu, H., Seitz, G., Seggewiss-Bernhardt, R., Leistner, R., Sterlacci, W., Vieth, M., Seidl, C., Mugler, M., Kapp, M., Hohenforst-Schmidt, W., Hartmann, A., Haller, F., & Erber, R. (2021). MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting. Cancers, 13(19), 5023. https://doi.org/10.3390/cancers13195023